Table 1 Clinical characteristics (n = 117)

Male (%)

105 (89.7)

Medical history

Hypertension (%)

74 (63.2)

Diabetes (%)

34 (29.1)

Hyperlipidemia (%)

16 (13.7)

Smoking (%)

32 (27.4)

Prior PCI (%)

46 (39.3)

Prior CABG (%)

9 (7.7)

Myocardial infarction history (%)

24 (20.5)

Clinical manifestation

Stable angina (%)

98 (83.8)

Acute coronary syndrome (%)

19 (16.2)

LVEF (%)

60.8 ± 6.6

Antithrombotic therapy during intervention

Heparin (%)

113 (96.6)

Bivalirudin (%)

4 (3.4)

Glycoprotein IIb/IIIa inhibitor (%)

14 (12.0)

Discharge medications

Aspirin (%)

105 (89.7)

Cilostazol (%)

12 (10.3)

Clopidogrel (%)

82 (70.1)

Ticagrelor (%)

35 (29.9)

Beta blocker (%)

90 (76.9)

RAS inhibitors (%)

76 (65.0)

Statin (%)

117 (100.0)

Ezetimibe (%)

12 (10.3)